Michael H. O’Shea

1.4k total citations
26 papers, 785 citations indexed

About

Michael H. O’Shea is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael H. O’Shea has authored 26 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael H. O’Shea's work include Renal Transplantation Outcomes and Treatments (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Michael H. O’Shea is often cited by papers focused on Renal Transplantation Outcomes and Treatments (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Michael H. O’Shea collaborates with scholars based in United States and Canada. Michael H. O’Shea's co-authors include Jeffrey Mulhern, Michael J. Germain, Gregory L. Braden, Steven B. Miller, Marc R. Hammerman, S Nash, Angelo A. Ucci, George S. Lipkowitz, Robert L. Madden and Michael J. Moulton and has published in prestigious journals such as Diabetes Care, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Michael H. O’Shea

26 papers receiving 736 citations

Peers

Michael H. O’Shea

NEPHR

MB

EDM

PRM

SURGE

Beatriz Bayés Spain

Carlo Rugiu Italy

Manuel Macı́a Spain

Z. Varghese United Kingdom

Carmen S. Amuchastegui Italy

Goce Spasovski North Macedonia

Annalisa Teutonico Italy

Francesco Locatelli Italy

C Jacobs France

Samir Mallat Lebanon

Beatriz Bayés Spain

Michael H. O’Shea

328 ×1.1

NEPHR

80 ×0.5

MB

141 ×0.9

EDM

87 ×0.7

PRM

252 ×2.3

SURGE

Citations per year, relative to Michael H. O’Shea Michael H. O’Shea (= 1×) peers Beatriz Bayés

Countries citing papers authored by Michael H. O’Shea

Since Specialization

Citations

This map shows the geographic impact of Michael H. O’Shea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. O’Shea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. O’Shea more than expected).

Fields of papers citing papers by Michael H. O’Shea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael H. O’Shea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. O’Shea. The network helps show where Michael H. O’Shea may publish in the future.

Co-authorship network of co-authors of Michael H. O’Shea

This figure shows the co-authorship network connecting the top 25 collaborators of Michael H. O’Shea. A scholar is included among the top collaborators of Michael H. O’Shea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael H. O’Shea. Michael H. O’Shea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Landry, Daniel L., et al.. (2018). Oxcarbazepine Therapy for Complete Central Diabetes Insipidus. Case Reports in Nephrology and Dialysis. 8(1). 20–24. 4 indexed citations

2.

Landry, Daniel L., et al.. (2015). Effects of Prolonged Ethanol Lock Exposure to Carbothane- and Silicone-based Hemodialysis Catheters: A 26-week Study. The Journal of Vascular Access. 16(5). 367–371. 10 indexed citations

3.

Singh, Gurmukteshwar, et al.. (2012). Successful Kidney Transplantation From a Hepatitis B Surface Antigen–Positive Donor to an Antigen-Negative Recipient Using a Novel Vaccination Regimen. American Journal of Kidney Diseases. 61(4). 608–611. 14 indexed citations

4.

Braden, Gregory L., Michael H. O’Shea, & Jeffrey Mulhern. (2005). Tubulointerstitial Diseases. American Journal of Kidney Diseases. 46(3). 560–572. 14 indexed citations

5.

O’Shea, Michael H., et al.. (2004). Acute renal failure and hyperkalaemia associated with cyclooxygenase-2 inhibitors. Nephrology Dialysis Transplantation. 19(5). 1149–1153. 28 indexed citations

6.

Khoo, Michelle S.C., Gregory L. Braden, David W. Deaton, et al.. (2003). Outcome and complications of intraoperative hemodialysis during cardiopulmonary bypass with potassium-rich cardioplegia. American Journal of Kidney Diseases. 41(6). 1247–1256. 11 indexed citations

7.

O’Connor, Andrew, Farhad Navab, Michael J. Germain, et al.. (2003). CASE REPORT: Pancreatitis and Duodenitis from Sarcoidosis: Successful Therapy with Mycophenolate Mofetil. Digestive Diseases and Sciences. 48(11). 2191–2195. 9 indexed citations

8.

Braden, Gregory L., Jeffrey Mulhern, Michael H. O’Shea, et al.. (2000). Changing incidence of glomerular diseases in adults. American Journal of Kidney Diseases. 35(5). 878–883. 184 indexed citations

9.

Madden, Robert L., Jeffrey Mulhern, Bernard Benedetto, et al.. (2000). Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients. Transplant International. 13(5). 344–350. 33 indexed citations

10.

Lipkowitz, George S., Robert L. Madden, Jeffrey Mulhern, et al.. (1999). Long-term maintenance of therapeutic cyclosporine levels leads to optimal graft survival without evidence of chronic nephrotoxicity. Transplant International. 12(3). 202–207. 12 indexed citations

11.

Lipkowitz, George S., Robert L. Madden, Jeffrey Mulhern, et al.. (1999). Long-term maintenance of therapeutic cyclosporine levels leads to optimal graft survival without evidence of chronic nephrotoxicity. Transplant International. 12(3). 202–207. 13 indexed citations

12.

Pavlakis, Steven G., Peter B. Kingsley, Gary P. Kaplan, et al.. (1998). Magnetic Resonance Spectroscopy. Archives of Neurology. 55(6). 849–849. 51 indexed citations

13.

Polk, Donna M., Robert L. Madden, George S. Lipkowitz, et al.. (1996). Use of Computerized Tomography in the Evaluation of a Capd Patient with a Foramen of Morgagni Hernia: A Case Report. Peritoneal Dialysis International. 16(3). 318–322. 1 indexed citations

14.

Polk, Donna M., Robert L. Madden, George S. Lipkowitz, et al.. (1996). Use of computerized tomography in the evaluation of a CAPD patient with a foramen of Morgagni hernia: a case report.. PubMed. 16(3). 318–20. 1 indexed citations

15.

Mulhern, Jeffrey, Gregory L. Braden, Michael H. O’Shea, et al.. (1995). Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients. American Journal of Kidney Diseases. 25(4). 611–615. 54 indexed citations

16.

Miller, Steven B., Michael J. Moulton, Michael H. O’Shea, & Marc R. Hammerman. (1994). Effects of IGF-I on renal function in end-stage chronic renal failure. Kidney International. 46(1). 201–207. 54 indexed citations

17.

Hammerman, Marc R., Michael H. O’Shea, & Steven B. Miller. (1993). Role of Growth Factors in Regulation of Renal Growth. Annual Review of Physiology. 55(1). 305–321. 34 indexed citations

18.

O’Shea, Michael H., et al.. (1993). Insulin-like growth factor I and the kidney.. PubMed. 13(1). 96–108. 8 indexed citations

19.

O’Shea, Michael H., Steven B. Miller, Kevin J. Finkel, & Marc R. Hammerman. (1993). Roles of growth hormone and growth factors in the pathogenesis and treatment of kidney disease. Current Opinion in Nephrology & Hypertension. 2(1). 67–72. 6 indexed citations

20.

Prìeto, Jesús, et al.. (1975). Serum ferritin assay and iron status in chronic renal failure and haemodialysis.. BMJ. 1(5957). 546–548. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact